178 related articles for article (PubMed ID: 19927342)
21. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
[TBL] [Abstract][Full Text] [Related]
23. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
24. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
25. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
26. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
[TBL] [Abstract][Full Text] [Related]
27. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice.
Hu PQ; Hurwitz AA; Oppenheim JJ
J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.
Hanke K; Dähnrich C; Brückner CS; Huscher D; Becker M; Jansen A; Meyer W; Egerer K; Hiepe F; Burmester GR; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R28. PubMed ID: 19232127
[TBL] [Abstract][Full Text] [Related]
29. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y
Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
[TBL] [Abstract][Full Text] [Related]
30. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
31. The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.
Hildebrandt S; Weiner E; Senécal JL; Noell S; Daniels L; Earnshaw WC; Rothfield NF
Arthritis Rheum; 1990 May; 33(5):724-7. PubMed ID: 2161233
[TBL] [Abstract][Full Text] [Related]
32. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
33. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
Morel PA; Chang HJ; Wilson JW; Conte C; Saidman SL; Bray JD; Tweardy DJ; Medsger TA
Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439
[TBL] [Abstract][Full Text] [Related]
34. Significant elevation of IgG anti-WRN (RecQ3 RNA/DNA helicase) antibody in systemic sclerosis.
Goto M; Okawa-Takatsuji M; Aotsuka S; Nakai H; Shimizu M; Goto H; Shimamoto A; Furuichi Y
Mod Rheumatol; 2006; 16(4):229-34. PubMed ID: 16906373
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
36. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1995 Sep; 155(5):2703-14. PubMed ID: 7650398
[TBL] [Abstract][Full Text] [Related]
37. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
[TBL] [Abstract][Full Text] [Related]
38. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.
Kuwana M; Medsger TA; Wright TM
J Clin Invest; 1995 Jul; 96(1):586-96. PubMed ID: 7615831
[TBL] [Abstract][Full Text] [Related]
39. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
40. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]